Individual patient data meta-analysis of survival data using Poisson regression models

被引:68
|
作者
Crowther, Michael J. [2 ]
Riley, Richard D. [1 ]
Staessen, Jan A. [3 ,4 ]
Wang, Jiguang [5 ]
Gueyffier, Francois [6 ]
Lambert, Paul C. [2 ,7 ]
机构
[1] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 7RH, Leics, England
[3] Univ Leuven, Dept Cardiovasc Res, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, BE-3000 Louvain, Belgium
[4] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Ctr Epidemiol Studies & Clin Trials, Shanghai 200025, Peoples R China
[6] INSERM, CIC201, F-69000 Lyon, France
[7] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
来源
关键词
PARTICIPANT DATA; META-REGRESSION; TIME; HETEROGENEITY; HAZARDS; TRIALS; FRAMEWORK; LEVEL; BIAS;
D O I
10.1186/1471-2288-12-34
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: An Individual Patient Data (IPD) meta-analysis is often considered the gold-standard for synthesising survival data from clinical trials. An IPD meta-analysis can be achieved by either a two-stage or a one-stage approach, depending on whether the trials are analysed separately or simultaneously. A range of one-stage hierarchical Cox models have been previously proposed, but these are known to be computationally intensive and are not currently available in all standard statistical software. We describe an alternative approach using Poisson based Generalised Linear Models (GLMs). Methods: We illustrate, through application and simulation, the Poisson approach both classically and in a Bayesian framework, in two-stage and one-stage approaches. We outline the benefits of our one-stage approach through extension to modelling treatment-covariate interactions and non-proportional hazards. Ten trials of hypertension treatment, with all-cause death the outcome of interest, are used to apply and assess the approach. Results: We show that the Poisson approach obtains almost identical estimates to the Cox model, is additionally computationally efficient and directly estimates the baseline hazard. Some downward bias is observed in classical estimates of the heterogeneity in the treatment effect, with improved performance from the Bayesian approach. Conclusion: Our approach provides a highly flexible and computationally efficient framework, available in all standard statistical software, to the investigation of not only heterogeneity, but the presence of non-proportional hazards and treatment effect modifiers.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Individual patient data meta-analysis of survival data using Poisson regression models
    Michael J Crowther
    Richard D Riley
    Jan A Staessen
    Jiguang Wang
    Francois Gueyffier
    Paul C Lambert
    BMC Medical Research Methodology, 12
  • [2] Practical methodology of meta-analysis of individual patient data using a survival outcome
    Katsahian, Sandrine
    Latouche, Aurelien
    Mary, Jean-Yves
    Chevret, Sylvie
    Porcher, Raphael
    CONTEMPORARY CLINICAL TRIALS, 2008, 29 (02) : 220 - 230
  • [3] One-step individual patient data (IPD) network meta-analysis of survival data using royston-parmar models
    Suzanne Freeman
    James Carpenter
    Jayne Tierney
    Trials, 16
  • [4] One-step individual patient data (IPD) network meta-analysis of survival data using royston-parmar models
    Freeman, Suzanne
    Carpenter, James
    Tierney, Jayne
    TRIALS, 2015, 16
  • [5] Meta-analysis of ordinal outcomes using individual patient data
    Whitehead, A
    Omar, RZ
    Higgins, JPT
    Savaluny, E
    Turner, RM
    Thompson, SG
    STATISTICS IN MEDICINE, 2001, 20 (15) : 2243 - 2260
  • [6] Rofecoxib for dysmenorrhoea: Meta-analysis using individual patient data
    Edwards J.E.
    Moore R.A.
    McQuay H.J.
    BMC Women's Health, 4 (1)
  • [7] On the equivalence of meta-analysis using literature and using individual patient data
    Dept. of Mathematics and Statistics, University of Maryland, 1000 Hilltop Circle, Baltimore, MD 21250, United States
    不详
    Biometrics, 4 (1221-1223):
  • [8] On the equivalence of meta-analysis using literature and using individual patient data
    Mathew, T
    BIOMETRICS, 1999, 55 (04) : 1221 - 1223
  • [9] Survival meta-analysis of individual patient data and survival meta-analysis of published (aggregate) data - Is there an intermediate approach between these two opposite options?
    Messori, A
    Trippoli, S
    Vaiani, N
    Cattel, F
    CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 309 - 316
  • [10] Individual patient data meta-analysis: An example
    Tu, Yu-Kang
    Pandis, Nikolaos
    Spineli, Loukia
    AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 2024, 166 (06) : 619 - 623